Halozyme Therapeutics, Inc. (0J2O.L)

USD 48.78

(0.12%)

Eps Summary of Halozyme Therapeutics, Inc.

  • Halozyme Therapeutics, Inc.'s latest annual eps in 2023 was 2.13 USD , up 43.92% from previous year.
  • Halozyme Therapeutics, Inc.'s latest quarterly eps in 2024 Q2 was 0.73 USD , up 19.67% from previous quarter.
  • Halozyme Therapeutics, Inc. reported an annual eps of 1.48 USD in 2022, down -48.25% from previous year.
  • Halozyme Therapeutics, Inc. reported an annual eps of 2.86 USD in 2021, up 201.05% from previous year.
  • Halozyme Therapeutics, Inc. reported a quarterly eps of 0.61 USD for 2024 Q1, down -7.58% from previous quarter.
  • Halozyme Therapeutics, Inc. reported a quarterly eps of 1.08 USD for 2024 Q3, up 47.95% from previous quarter.

Annual Eps Chart of Halozyme Therapeutics, Inc. (2023 - 2001)

Historical Annual Eps of Halozyme Therapeutics, Inc. (2023 - 2001)

Year Eps Eps Growth
2023 2.13 USD 43.92%
2022 1.48 USD -48.25%
2021 2.86 USD 201.05%
2020 0.95 USD 290.0%
2019 -0.50 USD 10.71%
2018 -0.56 USD -221.74%
2017 0.46 USD 156.79%
2016 -0.81 USD -224.0%
2015 -0.25 USD 55.36%
2014 -0.56 USD 24.32%
2013 -0.74 USD -54.17%
2012 -0.48 USD -152.63%
2011 -0.19 USD 66.07%
2010 -0.56 USD 16.42%
2009 -0.67 USD -9.84%
2008 -0.61 USD -90.62%
2007 -0.32 USD -33.33%
2006 -0.24 USD 7.69%
2005 -0.26 USD 0.0%
2004 -0.26 USD -2141.38%
2003 -0.01 USD 18.31%
2002 -0.01 USD 57.1%
2001 -0.03 USD 0.0%

Peer Eps Comparison of Halozyme Therapeutics, Inc.

Name Eps Eps Difference
Editas Medicine, Inc. -2.02 USD 205.446%
Dynavax Technologies Corporation -0.05 USD 4394.355%
Supernus Pharmaceuticals, Inc. 0.02 USD -8738.174%
Perrigo Company plc -0.09 USD 2368.371%
Illumina, Inc. -7.35 USD 128.98%
Thermo Fisher Scientific Inc. 15.53 USD 86.285%
Iovance Biotherapeutics, Inc. -1.89 USD 212.698%
Walgreens Boots Alliance, Inc. -10.01 USD 121.279%
IQVIA Holdings Inc. 7.39 USD 71.177%
Heron Therapeutics, Inc. -0.80 USD 366.25%
Regeneron Pharmaceuticals, Inc. 37.05 USD 94.251%
Unity Biotechnology, Inc. -2.70 USD 178.889%
Waters Corporation 10.87 USD 80.405%
Biogen Inc. 8.02 USD 73.441%
Sangamo Therapeutics, Inc. -1.48 USD 243.919%
Evolus, Inc. -1.08 USD 297.222%
Adicet Bio, Inc. -3.31 USD 164.35%
Cara Therapeutics, Inc. -2.19 USD 197.26%
bluebird bio, Inc. -1.93 USD 210.363%
Esperion Therapeutics, Inc. -2.03 USD 204.926%
FibroGen, Inc. -2.92 USD 172.945%
Agilent Technologies, Inc. 4.22 USD 49.526%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 120.66%
Homology Medicines, Inc. -7.41 USD 128.745%
Geron Corporation -0.32 USD 765.625%
Alnylam Pharmaceuticals, Inc. -3.52 USD 160.511%
Amicus Therapeutics, Inc. -0.51 USD 517.647%
Myriad Genetics, Inc. -1.39 USD 253.237%
Viking Therapeutics, Inc. -0.91 USD 334.066%
Intellia Therapeutics, Inc. -5.42 USD 139.299%
Zoetis Inc. 5.08 USD 58.071%
Abeona Therapeutics Inc. -2.53 USD 184.19%
Mettler-Toledo International Inc. 36.10 USD 94.1%
BioMarin Pharmaceutical Inc. 0.89 USD -139.326%
Vertex Pharmaceuticals Incorporated 14.05 USD 84.84%
Kala Pharmaceuticals, Inc. -17.35 USD 112.277%
Ionis Pharmaceuticals, Inc. -2.56 USD 183.203%
Atara Biotherapeutics, Inc. -65.18 USD 103.268%
Verastem, Inc. -3.96 USD 153.788%
Nektar Therapeutics -1.45 USD 246.897%
Axsome Therapeutics, Inc. -5.27 USD 140.417%
Aclaris Therapeutics, Inc. -1.27 USD 267.717%
Sarepta Therapeutics, Inc. -5.80 USD 136.724%
OPKO Health, Inc. -0.25 USD 952.0%
Exelixis, Inc. 0.65 USD -227.692%
Neurocrine Biosciences, Inc. 2.56 USD 16.797%
Corcept Therapeutics Incorporated 1.02 USD -108.824%
Anavex Life Sciences Corp. -0.60 USD 455.0%
uniQure N.V. -6.47 USD 132.921%
Imunon, Inc. -2.16 USD 198.611%
Blueprint Medicines Corporation -8.37 USD 125.448%
Insmed Incorporated -5.34 USD 139.888%
Agios Pharmaceuticals, Inc. -6.33 USD 133.649%
TG Therapeutics, Inc. 0.09 USD -2285.218%
Incyte Corporation 2.67 USD 20.225%
Emergent BioSolutions Inc. -14.85 USD 114.343%